Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
(Q39671100)
scientific article published on October 15, 2010
scientific article published on October 15, 2010
Language:
Current Data About
Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo